Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.9200
+0.0193 (2.14%)
At close: Mar 20, 2026, 4:00 PM EDT
0.9100
-0.0100 (-1.09%)
After-hours: Mar 20, 2026, 7:46 PM EDT

Senti Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2417306264-
Market Cap Growth
45.17%-43.80%-51.45%-2.54%--
Enterprise Value
41.5322.6727.77-1.33200.540
Last Close Price
0.923.516.6014.1098.60-
PE Ratio
--0.29-0.35-0.63-0.52-
PS Ratio
--11.7814.5023.09-
PB Ratio
2.980.660.450.49-0.57-
P/TBV Ratio
1.900.630.440.29-0.26-
P/FCF Ratio
--0.41-0.47-0.81-1.59-
P/OCF Ratio
--0.41-0.58-1.78-1.84-
EV/Sales Ratio
--10.85-0.3172.63-
EV/EBITDA Ratio
--0.41-0.320.02-5.36-
EV/EBIT Ratio
--0.37-0.300.02-4.96-
EV/FCF Ratio
--0.55-0.430.02-4.99-
Debt / Equity Ratio
3.070.570.500.280.350.40
Debt / EBITDA Ratio
-0.45-0.61-0.43-0.64-0.61-0.62
Debt / FCF Ratio
--0.81-0.58-0.49-0.57-0.56
Net Debt / Equity Ratio
2.20-0.570.03-0.480.300.28
Net Debt / EBITDA Ratio
-0.270.27-0.021.060.890.73
Net Debt / FCF Ratio
-0.36-0.030.810.830.65
Asset Turnover
-00.020.030.040.01
Quick Ratio
1.163.814.325.493.896.29
Current Ratio
1.514.495.625.684.146.52
Return on Equity (ROE)
-2.07%-89.73%-85.91%-52.94%-121.10%-63.41%
Return on Assets (ROA)
-88.10%-56.17%-61.76%-44.75%-55.77%-51.08%
Return on Invested Capital (ROIC)
-176.14%-103.36%-128.20%-126.14%-179.58%-165.78%
Return on Capital Employed (ROCE)
-105.80%-63.75%-68.80%-50.70%-64.38%-56.80%
Earnings Yield
-207.14%-342.74%-284.85%-158.16%-192.70%-
FCF Yield
-207.88%-244.38%-213.62%-122.76%-63.02%-
Buyback Yield / Dilution
--289.44%-2.94%-182.49%-2.33%-
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q